Physiologic (intraindividual) variation of serum prostate-specific antigen in 814 men from a screening population

Urology

Volumn 47, Issue 3, 1996, Pages 343-346

  Komatsu, Kazuto ^a   Wehner, Nancy ^a   Prestigiacomo, Anthony F ^a   Chen, Zuxiong ^a   Stamey, Thomas A ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER EPIDEMIOLOGY; CANCER SCREENING; DIAGNOSTIC ACCURACY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0029965666     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)80450-6     Document Type: Article

References (15)

1. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, and Redwine EA: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909-916, 1987.
2. Oesterling JE: Prostate-specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145: 907-923, 1991.
3. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, and Andriole GL: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324: 1156-1161, 1991.
4. Brawer MK, Chetner MP, Beatie J, Buchner DM, Vessella RL, and Lange PH: Screening for prostatic carcinoma with prostate specific antigen. J Urol 147: 841-845, 1992.
5. Cooner WH, Mosley BR, Rutherford CL Jr, Beard JH, Pond HS, Terry WJ, Igel TC, and Kidd DD: Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 143: 1146-1152, 1990.
6. Labrie F, Dupont A, Suburu R, Cusan L, Tremblay M, Gomez JL, and Emond J: Serum prostate specific antigen as pre-screening test for prostate cancer. J Urol 147: 846-852, 1992.
7. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, and Dalkin BL: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 151: 1283-1290, 1994.
8. Stamey TA: Making the most out of six systematic sextant biopsies. Urology 45: 2-12, 1995.
9. Carter HB, Pearson JD, Metter EJ, Brant LJ, Chan DW, Andres R, Fozard JL, and Walsh PC: Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267: 2215-2220, 1992.
10. Vessella RL, Noteboom J, and Lange PH: Evaluation of the Abbott IMx automated immunoassay of prostate-specific antigen. Clin Chem 38: 2044-2054, 1992.
11. Catalona WJ, Smith DS, and Ratliff TL: Value of measurements of the rate of change of serum PSA levels in prostate cancer screening (abstract 348). J Urol 149 (pt 2): 300A, 1993.
12. Brawer MK, Beatie J, Wener MH, Vessella RL, Preston SD, and Lange PH: Screening for prostatic carcinoma with prostate specific antigen: results of the second year. J Urol 150: 106-109, 1993.
13. Oesterling JE, Chute CG, Jacobsen SJ, Guess HA, Panser LA, Johnson CL, and Lieber MM: Longitudinal changes in serum PSA (PSA velocity) in a community-based cohort of men (abstract 799). J Urol 149 (pt 2): 412A, 1993.
14. Simak R, Madersbacher S, Zhang ZF, and Maier U: The impact of ejaculation on serum prostate specific antigen. J Urol 150: 895-897, 1993.
15. Riehmann M, Rhodes PR, Cook TD, Grose GS, and Gruskewitz RC: Analysis of variation in prostate-specific antigen values. Urology 42: 390-397, 1993.